
Clinical Research Manager
+1 415 514-8987
Publications
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection.
Science translational medicine
Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial.
The Lancet. Oncology
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19.
medRxiv : the preprint server for health sciences
First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody.
Nature communications
Accuracy of 18F-Fluorocholine PET for the Detection of Parathyroid Adenomas: Prospective Single-Center Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine